Skip to main content

Table 1 Patients’ characteristics

From: Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension

 

Number of patients (percentage of sample in parentheses)

Age

  <=60 years

1743 (65.1%)

  >60 years

936 (34.9%)

Gender

  Female

1439 (53.7%)

  Male

1240 (46.3%)

Body mass index

  <=25 kg/m2

309 (11.5%)

  >25 to < =30 kg/m2

1003 (37.4%)

  = > 30 kg/m2

1367 (51.0%)

Smoking status

  Current smoker

464 (17.3%)

  Ex-smoker

301 (11.2%)

  Non-smoker

1914 (71.4%)

Country

  Eastern European countries

1763 (65.8%)

  Western-central European countries

916 (34.2%)